166 related articles for article (PubMed ID: 20217594)
41. Fluorescent nanoparticle probes for cancer imaging.
Santra S; Dutta D; Walter GA; Moudgil BM
Technol Cancer Res Treat; 2005 Dec; 4(6):593-602. PubMed ID: 16292879
[TBL] [Abstract][Full Text] [Related]
42. Avidin-biotin capped mesoporous silica nanoparticles as an ion-responsive release system to determine lead(II).
Song W; Li J; Li Q; Ding W; Yang X
Anal Biochem; 2015 Feb; 471():17-22. PubMed ID: 25447495
[TBL] [Abstract][Full Text] [Related]
43. Effects of solid particle content on properties of o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Chevalier Y
J Colloid Interface Sci; 2010 Nov; 351(2):348-56. PubMed ID: 20800850
[TBL] [Abstract][Full Text] [Related]
44. Biotin-decorated fluorescent silica nanoparticles with aggregation-induced emission characteristics: fabrication, cytotoxicity and biological applications.
Li M; Lam JWY; Mahtab F; Chen S; Zhang W; Hong Y; Xiong J; Zheng Q; Tang BZ
J Mater Chem B; 2013 Feb; 1(5):676-684. PubMed ID: 32260772
[TBL] [Abstract][Full Text] [Related]
45. Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes.
Bottini M; D'Annibale F; Magrini A; Cerignoli F; Arimura Y; Dawson MI; Bergamaschi E; Rosato N; Bergamaschi A; Mustelin T
Int J Nanomedicine; 2007; 2(2):227-33. PubMed ID: 17722550
[TBL] [Abstract][Full Text] [Related]
46. Fluorescent silica nanoparticles with chemically reactive surface: Controlling spatial distribution in one-step synthesis.
Vera ML; Cánneva A; Huck-Iriart C; Requejo FG; Gonzalez MC; Dell'Arciprete ML; Calvo A
J Colloid Interface Sci; 2017 Jun; 496():456-464. PubMed ID: 28254612
[TBL] [Abstract][Full Text] [Related]
47. A novel method for synthesis of silica nanoparticles.
Rao KS; El-Hami K; Kodaki T; Matsushige K; Makino K
J Colloid Interface Sci; 2005 Sep; 289(1):125-31. PubMed ID: 15913636
[TBL] [Abstract][Full Text] [Related]
48. Fluorescent silica nanospheres for digital counting bioassay of the breast cancer marker HER2/neu [correction of HER2/nue].
Rossi LM; Shi L; Rosenzweig N; Rosenzweig Z
Biosens Bioelectron; 2006 Apr; 21(10):1900-6. PubMed ID: 16546369
[TBL] [Abstract][Full Text] [Related]
49. Preparation of Self-Activated Fluorescence Mesoporous Silica Hollow Nanoellipsoids for Theranostics.
Singh RK; Kim TH; Mahapatra C; Patel KD; Kim HW
Langmuir; 2015 Oct; 31(41):11344-52. PubMed ID: 26393922
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and characterization of oxazine-doped silica nanoparticles for their potential use as stable fluorescent reagents.
Godoy-Navajas J; Aguilar-Caballos MP; Gómez-Hens A
J Fluoresc; 2010 Jan; 20(1):171-80. PubMed ID: 19756983
[TBL] [Abstract][Full Text] [Related]
51. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging.
He Q; Ma M; Wei C; Shi J
Biomaterials; 2012 Jun; 33(17):4392-402. PubMed ID: 22425026
[TBL] [Abstract][Full Text] [Related]
52. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
53. Polycarboxylated Dextran as a Multivalent Linker: Synthesis and Target Recognition of the Antibody-Nanoparticle Bioconjugates in PBS and Serum.
Kunc F; Moore CJ; Sully RE; Hall AJ; Gubala V
Langmuir; 2019 Apr; 35(14):4909-4917. PubMed ID: 30817890
[TBL] [Abstract][Full Text] [Related]
54. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
[TBL] [Abstract][Full Text] [Related]
55. An ultra-sensitive SARS-CoV-2 antigen optical biosensor based on angiotensin converting enzyme 2 (ACE-2) functionalized magnetic-fluorescent silica nanoparticles.
Maulana MY; Raissa R; Nurrudin A; Andreani AS; Angelina M; Septiani NLW; Yuliarto B; Jenie SNA
Nanotechnology; 2024 Feb; 35(20):. PubMed ID: 38330490
[TBL] [Abstract][Full Text] [Related]
56. Functional silica nanoparticles synthesized by water-in-oil microemulsion processes.
Aubert T; Grasset F; Mornet S; Duguet E; Cador O; Cordier S; Molard Y; Demange V; Mortier M; Haneda H
J Colloid Interface Sci; 2010 Jan; 341(2):201-8. PubMed ID: 19875127
[TBL] [Abstract][Full Text] [Related]
57. Silica based hybrid materials for drug delivery and bioimaging.
Bagheri E; Ansari L; Abnous K; Taghdisi SM; Charbgoo F; Ramezani M; Alibolandi M
J Control Release; 2018 May; 277():57-76. PubMed ID: 29550399
[TBL] [Abstract][Full Text] [Related]
58. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding.
Bagwe RP; Hilliard LR; Tan W
Langmuir; 2006 Apr; 22(9):4357-62. PubMed ID: 16618187
[TBL] [Abstract][Full Text] [Related]
59. Size control of silica nanoparticles and their surface treatment for fabrication of dental nanocomposites.
Kim JW; Kim LU; Kim CK
Biomacromolecules; 2007 Jan; 8(1):215-22. PubMed ID: 17206810
[TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of poly(lipid)-coated, fluorophore-doped silica nanoparticles for biolabeling and cellular imaging.
Senarath-Yapa MD; Phimphivong S; Coym JW; Wirth MJ; Aspinwall CA; Saavedra SS
Langmuir; 2007 Dec; 23(25):12624-33. PubMed ID: 17975939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
